comparemela.com

Latest Breaking News On - Status of exchange - Page 1 : comparemela.com

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended.

United statesShan fuChiang liAntigua and barbudaState of delawareEnan wangMeng meiKenneth leeSimon andersonZheng renEastern caribbean supreme courtNasdaq stock marketSinovac biotech ltdDevices agencyExchange commissionUnited states district court

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

BEIJING (BUSINESS WIRE) Apr 29, 2024

State of delawareUnited statesAntigua and barbudaShan fuChiang liEnan wangMeng meiSimon andersonKenneth leeHelen yangZheng renDevices agencyEastern caribbean supreme courtUnited states district courtGlobe capitalExchange commission

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

BEIJING (BUSINESS WIRE) Apr 29, 2024

Shan fuEnan wangAntigua and barbudaUnited statesState of delawareChiang liZheng renMeng meiSimon andersonKenneth leeHelen yangDevices agencyDelaware chancery courtEastern caribbean supreme courtNational medical products administrationNasdaq stock market

SINOVAC Reports Unaudited First Half of 2023 Financial Results

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2023. First Half of 2023. -Today at 06:03 am- MarketScreener

United statesAntigua and barbudaState of delawareChiang liZheng renStatus of exchangeBarbuda international business corporationsAntigua courtUnited states district courtOrbimed advisorsStrategic developmentDelaware chancery courtSinovac biotech ltdGlobe capitalNasdaq stock marketEastern caribbean supreme court

SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended. | May 1, 2023

State of delawareUnited statesAntigua and barbudaChiang liHong kongZheng renBarbuda international business corporationsSinovac biotech ltdNasdaq stock marketChina national accreditation service for conformity assessmentStatus of exchangeEastern caribbean supreme courtWorld health organizationGlobe capitalExchange commissionDelaware chancery court

vimarsana © 2020. All Rights Reserved.